Africa's pharmaceutical market is on the cusp of a transformative era, projected to expand from USD 64.2 billion in 2025 to USD 118.3 billion by 2032, at an impressive CAGR of 9.10%. The surge in this sector is largely attributed to an increase in chronic disease cases, improvements in regulatory
In recent events that resonate deeply with those who value community over corporate, the closure of Central Drug Store, a San Francisco icon, marks the end of a quintessential American mainstay. For 117 years, this independent pharmacy stood resilient against the tide of vast retail chains, proving
In a monumental stride for pharmaceutical chemistry, researchers have developed a groundbreaking new class of ultra-stable chiral molecules that could redefine drug efficacy and safety. Chiral molecules, akin to a pair of gloves where the left and right hands are mirror images, play a pivotal role
In an era marked by rapid advancements in biotechnology, gene editing emerges as a promising frontier in the treatment of cardiovascular diseases. With the acquisition of Verve Therapeutics by Eli Lilly and Co., the pharmaceutical industry witnesses a strategic shift as major players venture deeper
The integration of artificial intelligence into Alzheimer's research has ignited significant interest as researchers seek innovative ways to enhance the efficiency and effectiveness of clinical trials. One study spearheaded by researchers at the University of Cambridge has gained attention,
The healthcare industry has encountered significant challenges, from regulatory hurdles to surging costs, prompting major players to reassess their strategies. UnitedHealth Group stands at the forefront of this movement, embracing innovation and value-based care approaches. This mindset reflects
